Clinical trials
Recruiting Phase 1 Diabetes Mellitus, Type 2 trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
40 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2022 | 3 |
| 2023 | 3 |
| 2024 | 5 |
| 2025 | 10 |
| 2026 | 19 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 40 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| The University of Texas Health Science Center at San Antonio | 5 |
| Novo Nordisk A/S | 4 |
| AstraZeneca | 2 |
| Neurotronic, Inc. | 2 |
| University of California, San Diego | 2 |
| 1Globe Health Institute | 1 |
| AC Immune SA | 1 |
| AdipoPharma LLC | 1 |
| Amgen | 1 |
| Case Western Reserve University | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Diabetes Mellitus, Type 2 | 40 |
| Obesity | 9 |
| Overweight | 6 |
| Diabetes Mellitus | 5 |
| Insulin Resistance | 3 |
| Hypertension | 2 |
| Metabolic Diseases | 2 |
| Renal Insufficiency, Chronic | 2 |
| Cardiovascular Diseases | 1 |
| Diabetes Mellitus, Type 1 | 1 |
Trials
Showing 1 to 25 of 40. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.